| Cardiac monocytes and macrophages after myocardial infarction C Peet, A Ivetic, DI Bromage, AM Shah Cardiovascular research 116 (6), 1101-1112, 2020 | 440 | 2020 |
| The impact of COVID‐19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic DI Bromage, A Cannatà, IA Rind, C Gregorio, S Piper, AM Shah, ... European journal of heart failure 22 (6), 978-984, 2020 | 215 | 2020 |
| Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis E Ammirati, L Lupi, M Palazzini, NS Hendren, JL Grodin, CV Cannistraci, ... Circulation 145 (15), 1123-1139, 2022 | 204 | 2022 |
| Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic A Banerjee, S Chen, L Pasea, AG Lai, M Katsoulis, S Denaxas, V Nafilyan, ... European journal of preventive cardiology 28 (14), 1599-1609, 2021 | 148 | 2021 |
| Temporal trends in decompensated heart failure and outcomes during COVID‐19: a multisite report from heart failure referral centres in London A Cannatà, DI Bromage, IA Rind, C Gregorio, C Bannister, M Albarjas, ... European journal of heart failure 22 (12), 2219-2224, 2020 | 122 | 2020 |
| Stromal derived factor 1α: a chemokine that delivers a two-pronged defence of the myocardium DI Bromage, SM Davidson, DM Yellon Pharmacology & therapeutics 143 (3), 305-315, 2014 | 114 | 2014 |
| Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis DI Bromage, JMJ Pickard, X Rossello, OJ Ziff, N Burke, DM Yellon, ... Cardiovascular research 113 (3), 288-297, 2017 | 111 | 2017 |
| Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment OJ Ziff, M Samra, JP Howard, DI Bromage, F Ruschitzka, DP Francis, ... BMC medicine 18, 1-11, 2020 | 87 | 2020 |
| The 10th biennial hatter cardiovascular institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio … SM Davidson, S Arjun, MV Basalay, RM Bell, DI Bromage, HE Bøtker, ... Basic Research in Cardiology 113, 1-11, 2018 | 80 | 2018 |
| Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models A Dyson, F Dal-Pizzol, G Sabbatini, AB Lach, F Galfo, ... PLoS medicine 14 (7), e1002310, 2017 | 56 | 2017 |
| Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment–elevation myocardial infarction and … MB Iqbal, C Ilsley, T Kabir, R Smith, R Lane, M Mason, P Clifford, T Crake, ... Circulation: Cardiovascular Quality and Outcomes 7 (6), 936-943, 2014 | 56 | 2014 |
| Outcome of 1051 octogenarian patients with ST‐segment elevation myocardial infarction treated with primary percutaneous coronary intervention: observational cohort from the … DI Bromage, DA Jones, KS Rathod, C Grout, MB Iqbal, P Lim, A Jain, ... Journal of the American Heart Association 5 (6), e003027, 2016 | 54 | 2016 |
| Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy OJ Ziff, DI Bromage, DM Yellon, SM Davidson Cardiovascular research 114 (3), 358-367, 2018 | 50 | 2018 |
| The pleiotropic effects of metformin: time for prospective studies DI Bromage, DM Yellon Cardiovascular diabetology 14, 1-4, 2015 | 47 | 2015 |
| Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis A Cannata, SA Watson, A Daniel, M Giacca, AM Shah, TA McDonagh, ... European journal of preventive cardiology 29 (8), 1266-1274, 2022 | 46 | 2022 |
| Out-of-hours primary percutaneous coronary intervention for ST-elevation myocardial infarction is not associated with excess mortality: a study of 3347 patients treated in an … KS Rathod, DA Jones, SM Gallagher, DI Bromage, M Whitbread, ... BMJ open 3 (6), e003063, 2013 | 42 | 2013 |
| Radial Versus Femoral Access Is Associated With Reduced Complications and Mortality in Patients With Non–ST-Segment–Elevation Myocardial Infarction: An Observational Cohort … MB Iqbal, A Arujuna, C Ilsley, A Archbold, T Crake, S Firoozi, S Kalra, ... Circulation: Cardiovascular Interventions 7 (4), 456-464, 2014 | 41 | 2014 |
| Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study DI Bromage, TR Godec, M Pujades-Rodriguez, A Gonzalez-Izquierdo, ... Cardiovascular Diabetology 18, 1-9, 2019 | 38 | 2019 |
| Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI KS Rathod, DA Jones, VS Rathod, D Bromage, O Guttmann, ... Coronary artery disease 25 (1), 52-59, 2014 | 38 | 2014 |
| The collateral cardiovascular damage of COVID-19: only history will reveal the depth of the iceberg A Cannata, DI Bromage, TA McDonagh European Heart Journal 42 (15), 1524-1527, 2021 | 36 | 2021 |